NSJ Bioreagents

The Cytokeratin 13 antibody can be used to study and characterize Cytokeratin 13, a member of the cytokeratin protein family which are structural proteins that make up the cytoskeleton of epithelial cells. These proteins are essential for maintaining the structural integrity of cells and tissues, as well as regulating cell growth, differentiation, and migration. Cytokeratin 13 is specifically found in certain types of epithelial cells, such as those in the oral cavity, esophagus, and skin. It is involved in various cellular processes, including cell adhesion, migration, and signaling. Additionally, cytokeratin 13 has been implicated in diseases such as oral cancer, where its expression levels are altered. Studies have shown that abnormal expression of cytokeratin 13 can be indicative of certain diseases, making it a potential biomarker for diagnostic purposes. Understanding the role of this protein in disease progression can help in the development of targeted therapies and treatments.

The Cytokeratin 13 antibody, a vital tool in the realm of cell biology and cancer research, has revolutionized various techniques like western blot, flow cytometry, immunofluorescence, immunohistochemistry, and ELISA and can be used to study this important protein. Cytokeratin 13 antibody is commonly employed in western blotting to detect and study the presence of Cytokeratin 13 protein in cell lysates. This technique allows researchers to quantify protein expression levels and analyze post-translational modifications. Flow cytometry is a powerful tool that uses a Cytokeratin 13 antibody to analyze the surface expression of Cytokeratin 13 in individual cells. This technique is essential for characterizing cell populations based on protein expression profiles. Immunofluorescence staining with a Cytokeratin 13 antibody enables researchers to visualize the subcellular localization of Cytokeratin 13 protein within cells. This technique is valuable for understanding cell morphology and structure. In immunohistochemistry, a Cytokeratin 13 antibody is used to detect the presence of Cytokeratin 13 in tissue samples. This method is crucial for diagnosing and studying various types of cancers, as abnormal Cytokeratin 13 expression is often associated with malignancies. Enzyme-linked immunosorbent assay (ELISA) with Cytokeratin 13 antibody is a sensitive and specific method for quantifying Cytokeratin 13 levels in biological samples. This technique is commonly used in research and clinical settings to monitor disease progression and treatment outcomes.

The Cytokeratin 13 antibody is a versatile tool that plays a crucial role in various laboratory techniques, including western blot, flow cytometry, immunofluorescence, immunohistochemistry, and ELISA. Its applications extend beyond basic research to translational and clinical studies, making it an indispensable component in the field of cell biology and cancer research.